January 30, 2002GlaxoSmithKline Has Recalled Anectine and
Zebulon, NC (SafetyAlerts)
- The Food and Drug Administration (FDA) said that GlaxoSmithKline has recalled
Anectine (succinylcholine chloride) Injection and Retrovir (zidovudine) IV
Anectine (succinylcholine chloride) Injection, 200 mg/10mL (20mg/mL),10 mL
Multiple Dose vial, Rx only, Recall # D-088-2;
Retrovir (zidovudine) IV Infusion, sterile, 10 mL/mL, 20 mL single use vial,
Tray of 10 vials, Rx only, Recall # D-089-2.
Anectine Injection - Lot Number 0L2080;
Retrovir IV Infusion - Lot Number 9K2300.
Recalling Firm: GlaxoSmithKline Zebulon, NC, by letter on Nov. 5, 2001.
Manufacturer: DSM Catalytica Pharmaceuticals, Greenville, NC. Firm initiated
recall is ongoing.
Lack of assurance of sterility (glassware may exhibit cracks).
VOLUME OF PRODUCT IN COMMERCE
Anectine - 8,162 units and Retrovir - 1,062 units.